AVADEL PHARMACEUTICALS PLC — Director's Dealing 2019

Nov 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2019-10-22

Reporting Person: Vaughn Jason (Sr. VP, Technical Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-22	Stock Option (right to buy)	$3.45	A	150000	Acquired	2029-10-22	ADSs (150000)	Direct

Footnotes

F1: Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 10/22/2019 grant date.

F2: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.